StockClub
NRSNWNeuroSense Therapeutics Ltd.$ --
NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

NRSNW

$ -

-

You can review balance sheet highlights, composition, equity ratio trends, and annual balance sheet line items.

account_balanceBalance Sheet (BS) Summary

2024/12 Filed: 2025-04-07

Total Assets

account_balance
4.6M USD
No comparison

Shareholders' Equity

savings
2.6M USD
No comparison

Equity Ratio

pie_chart
56.5%
No comparison

Book Value Per Share

paid
0.1USD
No comparison

Asset & Liability Mix

Non-current AssetsCurrent AssetsEquityNon-current LiabilitiesCurrent Liabilities

Equity Ratio Trend (5 Years)

Unit: %
806040200
2020
2021
2022
2023
2024

Balance Sheet Details

Item
2019
2020
2021
2022
2023
2024
Cash
Cash and Equivalents
Short-term Investments
Net Receivables
Inventory
Other Current Assets
Total Current Assets
3.38M
3.38M
0
164,000
0
35,000
4.40M
Goodwill
Intangible Assets
Property, Plant and Equipment
Property, Plant and Equipment Net
Long-term Investments
Other Assets
Other Non-current Assets
Net Tangible Assets
Non-current Assets Total
Total Assets
0
0
150,000
150,000
23,000
0
0
4.58M
173,000
4.58M
Accounts Payable
Short-term Debt
Short/Current Long-term Debt
Current Deferred Revenue
Other Current Liabilities
Total Current Liabilities
1.16M
73,000
73,000
0
188,000
1.99M
Long-term Debt
Long-term Debt Total
Capital Lease Obligations
Other Non-current Liabilities
Net Debt
Non-current Liabilities Total
Total Liabilities
0
73,000
73,000
0
-3.31M
0
1.99M
Common Stock
Common Stock Shares Outstanding
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income
Other Stockholder Equity
Treasury Stock
Total Stockholder Equity
0
18.60M
39.24M
-36.66M
0
0
0
2.58M

Unlock Long-Term Balance Sheet Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.